| Literature DB >> 33687053 |
Yijin Chen1,2,3, Tong Xu1,2,3, Mengsha Li1,2,3, Chuling Li1,2,3, Yusheng Ma1,2,3, Guojun Chen1,2,3, Yili Sun1,2,3, Hao Zheng1,2,3, Guangkai Wu1,2,3, Wangjun Liao4, Yulin Liao1,2,3, Yanmei Chen1,2,3, Jianping Bin1,2,3.
Abstract
Post-translational modification (PTM) by small ubiquitin-like modifier (SUMO) is a key regulator of cell proliferation and can be readily reversed by a family of SUMO-specific proteases (SENPs), making SUMOylation an ideal regulatory mechanism for developing novel therapeutic strategies for promoting a cardiac regenerative response. However, the role of SUMOylation in cardiac regeneration remains unknown. In the present study, we assessed whether targeting protein kinase B (Akt) SUMOylation can promote cardiac regeneration. Quantitative PCR and Western blotting results showed that small ubiquitin-like modifier-specific protease 2 (SENP2) is up-regulated during postnatal heart development. SENP2 deficiency promoted P7 and adult cardiomyocyte (CM) dedifferentiation and proliferation both in vitro and in vivo. Mice with SENP2 deficiency exhibited improved cardiac function after MI due to CM proliferation and angiogenesis. Mechanistically, the loss of SENP2 up-regulated Akt SUMOylation levels and increased Akt kinase activity, leading to a decrease in GSK3β levels and subsequently promoting CM proliferation and angiogenesis. In summary, inhibition of SENP2-mediated Akt deSUMOylation promotes CM differentiation and proliferation by activating the Akt pathway. Our results provide new insights into the role of SUMOylation in cardiac regeneration.Entities:
Keywords: Akt pathway; Cardiac regeneration; SENP2; SUMOylation
Year: 2021 PMID: 33687053 DOI: 10.1042/CS20201408
Source DB: PubMed Journal: Clin Sci (Lond) ISSN: 0143-5221 Impact factor: 6.124